Michael R. Hayden serves as Executive at Xenon Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Michael R. Hayden has executed 56 insider transactions totaling $5.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 30, 2025 involved transacting 103,978 shares valued at $0.
Michael R. Hayden currently holds 54,298 shares of Xenon Pharmaceuticals Inc. (XENE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael R. Hayden has been a net buyer of XENE stock. They have purchased $3.2M and sold $2.5M worth of shares.
Michael R. Hayden's most recent insider trade was on Oct 30, 2025, when they sold 103,978 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 30, 2025 | ETNB | $0 | Tender | 80,904 | $N/A | Discretionary |
| Jul 15, 2025 | IONS | $0 | Option Exercise | 4,079 | $N/A | Discretionary |
| Sep 22, 2023 | ABCL | $98.2K | Purchase | 20,000 | $4.91 | Discretionary |
| Aug 8, 2023 | ABCL | $177.0K | Purchase | 30,000 | $5.90 | Discretionary |
| Jul 17, 2023 | IONS | $0 | Option Exercise | 5,333 | $N/A | Discretionary |
| Jul 17, 2023 | IONS | $0 | Option Exercise | 1,777 | $N/A | Discretionary |
| Mar 28, 2023 | ETNB | $993.8K | Purchase | 61,538 | $16.15 | Discretionary |
| Oct 17, 2022 | IONS | $0 | Option Exercise | 1,777 | $N/A | Discretionary |
| Jul 15, 2022 | IONS | $0 | Option Exercise | 1,777 | $N/A | Discretionary |
| Jul 15, 2022 | IONS | $0 | Option Exercise | 5,333 | $N/A | Discretionary |
| Apr 25, 2022 | ETNB | $26.7K | Purchase | 10,000 | $2.67 | Discretionary |
| Apr 7, 2022 | ETNB | $34.8K | Purchase | 10,000 | $3.48 | Discretionary |
| Mar 30, 2022 | ETNB | $22.6K | Purchase | 6,250 | $3.62 | Discretionary |
| Oct 15, 2021 | IONS | $0 | Option Exercise | 1,777 | $N/A | Discretionary |
| Sep 13, 2021 | ABCL | $4.8M | Option Exercise | 270,000 | $17.73 | Discretionary |
| Jul 15, 2021 | IONS | $0 | Option Exercise | 1,778 | $N/A | Discretionary |
| Jul 15, 2021 | IONS | $0 | Option Exercise | 5,333 | $N/A | Discretionary |
| Jun 22, 2021 | ABCL | $2.5M | Sale | 100,000 | $25.50 | Discretionary |
| May 18, 2021 | XENE | $13.5K | Option Exercise | 3,500 | $3.85 | Discretionary |
| Feb 23, 2021 | ETNB | $42.4K | Option Exercise | 13,637 | $3.11 | Discretionary |
| Feb 23, 2021 | ETNB | $12.4K | Option Exercise | 6,447 | $1.93 | Discretionary |
| Feb 23, 2021 | ETNB | $117.4K | Option Exercise | 60,820 | $1.93 | Discretionary |
| Feb 18, 2021 | XENE | $37.8K | Option Exercise | 10,288 | $3.67 | Discretionary |
| Feb 18, 2021 | XENE | $82.7K | Option Exercise | 30,864 | $2.68 | Discretionary |
| Feb 16, 2021 | XENE | $13.8K | Option Exercise | 5,144 | $2.68 | Discretionary |
| Jan 29, 2021 | AUPH | $96.3K | Option Exercise | 15,000 | $6.42 | Discretionary |
| Jan 29, 2021 | AUPH | $272.0K | Option Exercise | 50,000 | $5.44 | Discretionary |
| Jan 29, 2021 | AUPH | $181.8K | Option Exercise | 30,000 | $6.06 | Discretionary |